HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jamie A Cesaretti Selected Research

Prostatic Neoplasms (Prostate Cancer)

12/2016Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
6/2011Update on prostate brachytherapy: long-term outcomes and treatment-related morbidity.
8/2010Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer.
12/2009Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy.
9/2009Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
7/2009Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.
7/2008Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
7/2008Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.
3/2008TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.
9/2007Brachytherapy for the treatment of prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jamie A Cesaretti Research Topics

Disease

20Prostatic Neoplasms (Prostate Cancer)
12/2016 - 06/2003
4Neoplasms (Cancer)
02/2008 - 03/2006
3Breast Neoplasms (Breast Cancer)
12/2016 - 03/2006
3Neoplasm Metastasis (Metastasis)
01/2012 - 10/2006
2Erectile Dysfunction
04/2009 - 03/2008
2Hemorrhage
03/2008 - 08/2007
1Urinary Incontinence
04/2010
1Urinary Retention
02/2010
1Adenocarcinoma
07/2008
1Radiation Injuries (Radiation Sickness)
07/2008
1Squamous Cell Carcinoma of Head and Neck
02/2008
1Proctitis
08/2007
1Ulcerative Colitis
10/2006
1Crohn Disease (Crohn's Disease)
10/2006
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2006
1Inflammatory Bowel Disease 17
10/2006
1Fibrosis (Cirrhosis)
03/2006
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2005

Drug/Important Bio-Agent (IBA)

4Prostate-Specific Antigen (Semenogelase)IBA
06/2011 - 06/2003
2Hormones (Hormone)IBA
08/2010 - 07/2008
2A 103 (A-103)IBA
12/2009 - 08/2007
2DNA (Deoxyribonucleic Acid)IBA
03/2008 - 03/2006
1Sunitinib (Sutent)FDA Link
01/2012
1Protons (Proton)IBA
06/2011
1Biological ProductsIBA
04/2010
1Dihydrotachysterol (AT 10)IBA
07/2008
1Codon (Codons)IBA
03/2006
1IsotopesIBA
02/2006
1AndrogensIBA
08/2004

Therapy/Procedure

17Brachytherapy
06/2011 - 08/2004
14Radiotherapy
12/2016 - 08/2004
9Therapeutics
08/2010 - 06/2003
2Aftercare (After-Treatment)
08/2010 - 03/2006
2Transurethral Resection of Prostate (TURP)
02/2010 - 10/2004
1Image-Guided Radiotherapy
01/2012
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2011
1Adjuvant Radiotherapy
02/2008